Sensus Healthcare (SRTS) vs TELA Bio (TELA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Sensus Healthcare (SRTS) has outperformed TELA Bio (TELA) over the past year, losing 13.9% versus a loss of 31.8%. Over five years, SRTS leads with a -26.3% price change compared with -91.5% for TELA. Sensus Healthcare is the larger company by market cap ($48.9 million vs $47.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SRTS | TELA |
|---|---|---|
| Share price | $2.97 | $1.05 |
| Market cap | $48.89M | $47.40M |
| 1-day change | +1.02% | -1.87% |
| YTD return | -25.38% | -9.32% |
| 1-year return | -13.91% | -31.85% |
| 5-year return | -26.32% | -91.51% |
| EPS (TTM) | $-0.94 | $-0.77 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.49 | $1.56 |
| 52-week low | $2.66 | $0.501 |
| Distance from 52-week high | -45.90% | -32.69% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +81.14% | +98.10% |
| Average volume | 29.46K | 213.37K |
| Shares outstanding | 16.46M | 45.14M |
| Employees | 60 | 218 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SRTS has outperformed TELA by 17.9 percentage points over the past year.
About Sensus Healthcare
SRTS stock →Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.
Healthcare · Medical Devices · 60 employees
About TELA Bio
TELA stock →TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs.
Healthcare · Medical Devices · 218 employees
SRTS vs TELA FAQ
Which is bigger, Sensus Healthcare or TELA Bio?
Sensus Healthcare (SRTS) is larger, with a market capitalization of $48.89M compared with $47.40M for TELA Bio (TELA).
Which stock has performed better over the past year, SRTS or TELA?
SRTS returned -13.91% over the past 12 months, compared with -31.85% for TELA (price return, excluding dividends). Past performance does not predict future results.
Are Sensus Healthcare and TELA Bio in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.